THE QUALITY AND EQUIVALENCE OF TOPICAL
PRODUCTS AND CHALLENGES Of NANOTECHNOLOGY
Specialized in the field of preclinical studies Labhnn is organizing its first hybrid workshop with the contribution of international experts
The hybrid event happen on 6 April 2021 -follow us now on the blog
Workshop
EMA’s proposed guideline on quality and equivalence of topical products - future advances and challenges
On 6 April 2021
SPEAKERs
PROF. YOGESHVAR KALIA
Professor Kalia has worked in biopharmaceutics (speciality: transdermal drug delivery), first at the University of California – San Francisco since 1994
Read More...
PROF. RICHARD GUY
Richard Guy received an M.A. in Chemistry from Oxford University, and his Ph.D. in Pharmaceutical Chemistry from the UCL School of Pharmacy.
Read More...
DR. VINOD SHAH
Dr. Shah is a Pharmaceutical Consultant. He worked at US Food and Drug Administration (FDA) for over 30 years and developed several Regulatory Guidances
Read More...
PROF. STEFAN MUHLEBACH
Professor Mühlebach is a trained hospital pharmacist and pharmacologist. He worked for 25 years as head pharmacy in the hospital of Biel/Bienne
Read More...
Dr. Maria Lapteva
Dr. Maria Lapteva is currently occupying senior scientist in Prof. Kalia’s group. She has over 10 years of experience in preclinical drug development
Read More...
PROF. Christian Surber
Christian Surber, Ph.D., is Professor of Dermatopharmacology and Hospital Pharmacy at the University of Basel and visiting Professor at the Departments of Dermatology
Read More...
Looking for targeted customer ?
Meet decision makers in the pharmaceutical and cosmetic industry
Show off your solutions to key influencers
Gain visibility by editorial relay on labhnn communications
TEAM
ELUAN ALEJO
Photographer & Video Editing
PAULINE BAENI
Website
PASCALE GARGANTINI
Marketing & Logistics
JEAN-DAVID URFER
TV Journalist
VENUE
For your venue we propose to book a room at Hotel Le Cenacle at 17, promenade Charles-Martin, 1208 Geneva .
Stay up to date
Labhnn Hybrid Workshop on 6 April 2021 – BASF Platin Sponsor
You never formulated a topical medicated product, and you wish to speed up its development. How to start?
Include early clinical results in the development of your topical dermal product
How to include early clinical results in the development of your topical dermal product?
RiverD, has a solution. Watch our interview
Molecular therapeutics delivery group
Introduction of Dr. Maria Lapteva from University of Geneva Meet Dr. Maria Lapteva, senior scientist at Prof. Kalia’s lab in the Pharmaceutical School of the University of Geneva. She will talk about nanoparticles in skin
English
French
German
Italian
Portuguese
Russian
Spanish